SORAFENIB

Description

Sorafenib – Targeted Therapy for Advanced Cancers

Overview

Sorafenib is a prescription oral medication classified as a multi-kinase inhibitor, designed to treat certain advanced cancers by blocking enzymes that promote tumor growth and blood vessel formation. Sorafenib is commonly used in the treatment of advanced hepatocellular carcinoma (HCC), advanced renal cell carcinoma (RCC), and differentiated thyroid carcinoma (DTC), helping to slow disease progression and improve patient outcomes.

Key Features / Indications

• Active Ingredient: Sorafenib
• Therapeutic Class: Multi-Kinase Inhibitor / Targeted Therapy
• Indications:

o Advanced hepatocellular carcinoma (HCC)

o Advanced renal cell carcinoma (RCC)

o Differentiated thyroid carcinoma (DTC) refractory to radioactive iodine

• Administration: Oral tablets, taken twice daily or as prescribed
• Mechanism of Action: Inhibits multiple kinases involved in tumor cell proliferation and angiogenesis, reducing tumor growth and metastasis
• Benefits:

o Targeted therapy for multiple advanced cancers

o Oral administration for patient convenience

o Slows tumor progression and improves survival in previously treated patients

Why Choose Oncomed Pharmacy?

Oncomed Pharmacy provides authentic, high-quality Sorafenib with safe storage, handling, and professional guidance. Our pharmacists offer support for proper dosing, side-effect management, and ongoing patient care, ensuring therapy is both safe and effective. Choosing Oncomed Pharmacy guarantees access to essential oncology medications with dedicated support throughout your treatment journey.

Uses of Medicine

Sorafenib is primarily used for:

• Treating advanced hepatocellular carcinoma (HCC)
• Managing advanced renal cell carcinoma (RCC)
• Treating differentiated thyroid carcinoma (DTC) resistant to radioactive iodine
• Slowing tumor growth and disease progression in advanced cancers
• Supporting targeted therapy regimens for improved outcomes